United States Biotechnology & Medical Research

Day One Biopharmaceuticals Inc (DAWN)

Track

Track

Day One Biopharmaceuticals experienced notable insider trading activity on February 17, 2026. Multiple executives, including the CEO and CFO, executed sales of company shares. These transactions represent the most recent recorded movements, following a similar pattern observed during November 2025. No further significant equity acquisitions or disposals have been reported since that date.
Ticker: DAWN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Day One Biopharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Merendino Lauren Chief Commercial Officer Officer
Transaction date
Sale
Price
100.07
Quantity 66,784 -40.0%
Value US$4,892,834
3.0
Dubow Adam Gen Counsel & Secretary Officer
Transaction date
Sale
Price
226.08
Quantity 55,484 +11.5%
Value US$2,436,340
3.2
York Charles N II COO and CFO Officer
Transaction date
Sale
Price
116.55
Quantity 84,813 -43.6%
Value US$2,007,958
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
11.60
Quantity 15,459 -7.0%
Value US$179,338
VASCONCELLES MICHAEL Head of Research and Dev. Officer
Transaction date
Sale
Price
11.60
Quantity 2,728 -38.3%
Value US$31,647
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
11.60
Quantity 15,459
Value US$179,338
3.2
CHARLES YORK Officer Officer
Transaction date
Proposed sale
Price
11.60
Quantity 6,065
Value US$70,359
1.6
LAUREN MERENDINO Officer Officer
Transaction date
Proposed sale
Price
11.60
Quantity 5,814
Value US$67,448
3.0
ADAM DUBOW Officer Officer
Transaction date
Proposed sale
Price
11.60
Quantity 6,395
Value US$74,188
1.6
Merendino Lauren Chief Commercial Officer Officer
Transaction date
Sale
Price
8.91
Quantity 3,726 -6.8%
Value US$33,216
3.2
York Charles N II COO and CFO Officer
Transaction date
Sale
Price
8.91
Quantity 4,062 -1.4%
Value US$36,212
3.0
Dubow Adam Gen Counsel & Secretary Officer
Transaction date
Sale
Price
8.91
Quantity 4,319 -6.5%
Value US$38,503
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
8.91
Quantity 15,894 -8.2%
Value US$141,690
3.2
CHARLES YORK Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 4,062
Value US$36,211
1.6
LAUREN MERENDINO Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 3,726
Value US$33,216
3.0
ADAM DUBOW Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 4,319
Value US$38,502
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.91
Quantity 15,894
Value US$141,689
3.2
York Charles N II COO and CFO Officer
Transaction date
Sale
Price
6.77
Quantity 4,106 -1.5%
Value US$27,786
3.0
Dubow Adam Gen Counsel & Secretary Officer
Transaction date
Sale
Price
6.77
Quantity 4,365 -7.4%
Value US$29,538
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
6.77
Quantity 16,058 -9.1%
Value US$108,666
1.6
Merendino Lauren Chief Commercial Officer Officer
Transaction date
Sale
Price
6.77
Quantity 3,766 -8.2%
Value US$25,485
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.77
Quantity 16,058
Value US$108,666
1.6
Merendino Lauren Chief Commercial Officer Officer
Transaction date
Sale
Price
6.26
Quantity 3,927 -10.0%
Value US$24,575
3.0
Dubow Adam GENERAL COUNSEL Officer
Transaction date
Sale
Price
6.26
Quantity 4,552 -8.8%
Value US$28,486
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Sale
Price
6.26
Quantity 4,282 -1.6%
Value US$26,796
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
6.26
Quantity 13,964 -8.7%
Value US$87,385
3.2
CHARLES YORK Officer Officer
Transaction date
Proposed sale
Price
6.26
Quantity 4,282
Value US$26,796
1.6
LAUREN MERENDINO Officer Officer
Transaction date
Proposed sale
Price
6.26
Quantity 3,927
Value US$24,575
3.0
ADAM DUBOW Officer Officer
Transaction date
Proposed sale
Price
6.26
Quantity 4,552
Value US$28,486
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.26
Quantity 13,964
Value US$87,385
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Sale
Price
11.96
Quantity 4,370 -1.7%
Value US$52,278
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
11.96
Quantity 12,048 -8.6%
Value US$144,130
3.0
Dubow Adam GENERAL COUNSEL Officer
Transaction date
Sale
Price
11.96
Quantity 4,646 -10.5%
Value US$55,580
3.0
ADAM DUBOW Officer Officer
Transaction date
Proposed sale
Price
11.96
Quantity 4,646
Value US$55,580
3.2
CHARLES YORK Officer Officer
Transaction date
Proposed sale
Price
11.96
Quantity 4,370
Value US$52,278
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
11.96
Quantity 12,048
Value US$144,129
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
13.31
Quantity 30,000 -2.8%
Value US$399,339
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
13.21
Quantity 10,554 -8.9%
Value US$139,420
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Sale
Price
13.21
Quantity 2,206 -0.2%
Value US$29,142
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Sale
Price
13.21
Quantity 2,602 -1.1%
Value US$34,373
3.0
Dubow Adam GENERAL COUNSEL Officer
Transaction date
Sale
Price
13.21
Quantity 3,165 -9.0%
Value US$41,810
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
13.21
Quantity 2,206
Value US$29,142
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
13.21
Quantity 10,554
Value US$139,420
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
16.39
Quantity 50,000
Value US$819,500
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.10
Quantity 10,000 -0.9%
Value US$160,994
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.17
Quantity 18,255 -1.7%
Value US$295,229
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.03
Quantity 11,245 -1.0%
Value US$180,287
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.02
Quantity 500 -0.0%
Value US$8,010
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
14.47
Quantity 30,000
Value US$434,100
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
14.22
Quantity 30,000 -2.7%
Value US$426,675
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Sale
Price
14.00
Quantity 2,633 -1.1%
Value US$36,860
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Sale
Price
14.00
Quantity 2,232 -0.2%
Value US$31,246
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
14.00
Quantity 10,681 -9.7%
Value US$149,524
3.0
Dubow Adam GENERAL COUNSEL Officer
Transaction date
Sale
Price
14.00
Quantity 3,202 -10.6%
Value US$44,825
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.00
Quantity 10,681
Value US$149,524
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 2,232
Value US$31,246
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.01
Quantity 20,000 -1.8%
Value US$320,226
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
15.70
Quantity 80,000
Value US$1,256,000
1.8
SAIRA RAMASASTRY Director Non-Executive Director
Transaction date
Proposed sale
Price
13.19
Quantity 10,000
Value US$131,877
1.8
Ramasastry Saira Non-Executive Director
Transaction date
Sale
Price
13.19
Quantity 10,000 -19.8%
Value US$131,877
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
12.62
Quantity 30,000 -2.6%
Value US$378,588
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
12.77
Quantity 30,000
Value US$383,100
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Sale
Price
16.08
Quantity 2,267 -0.2%
Value US$36,450
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Sale
Price
16.08
Quantity 2,675 -1.2%
Value US$43,011
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
16.08
Quantity 7,873 -1.2%
Value US$126,588
3.0
Dubow Adam GENERAL COUNSEL Officer
Transaction date
Sale
Price
16.08
Quantity 3,253 -13.0%
Value US$52,304
3.0
ADAM DUBOW Officer Officer
Transaction date
Proposed sale
Price
16.08
Quantity 3,253
Value US$52,304
3.2
JEREMY BENDER Officer; Director Executive Director
Transaction date
Proposed sale
Price
16.08
Quantity 7,873
Value US$126,587
3.2
CHARLES YORK Officer Officer
Transaction date
Proposed sale
Price
16.08
Quantity 2,675
Value US$43,010
3.8
SAMUEL BLACKMAN Officer Officer
Transaction date
Proposed sale
Price
16.08
Quantity 2,267
Value US$36,450
3.8
Blackman Samuel C. HEAD OF R&D Officer
Transaction date
Planned sale
Price
16.37
Quantity 10,000 -0.9%
Value US$163,743
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
17.85
Quantity 9,154 -1.4%
Value US$163,417
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Planned sale
Price
17.85
Quantity 8,078 -3.6%
Value US$144,214
3.2
Bender Jeremy CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
17.94
Quantity 6 -0.0%
Value US$108
3.2
York Charles N II COO, CFO AND SECRETARY Officer
Transaction date
Planned sale
Price
17.90
Quantity 200 -0.1%
Value US$3,579
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-18 2026-02-17 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
66,784 -40.0%
100.07
US$4,892,834 		66,784 -40.0% 100.07 US$4,892,834
2026-02-18 2026-02-17 S Sale
3.0
Dubow Adam

Gen Counsel & Secretary

Officer
55,484 +11.5%
226.08
US$2,436,340 		55,484 +11.5% 226.08 US$2,436,340
2026-02-18 2026-02-17 S Sale
3.2
York Charles N II

COO and CFO

Officer
84,813 -43.6%
116.55
US$2,007,958 		84,813 -43.6% 116.55 US$2,007,958
2026-02-18 2026-02-17 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
15,459 -7.0%
11.60
US$179,338 		15,459 -7.0% 11.60 US$179,338
2026-02-18 2026-02-17 S Sale
VASCONCELLES MICHAEL

Head of Research and Dev.

Officer
2,728 -38.3%
11.60
US$31,647 		2,728 -38.3% 11.60 US$31,647
2026-02-17 2026-02-17 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
15,459
11.60
US$179,338 		15,459 11.60 US$179,338
2026-02-17 2026-02-17 PrS Proposed sale
3.2
CHARLES YORK

Officer

Officer
6,065
11.60
US$70,359 		6,065 11.60 US$70,359
2026-02-17 2026-02-17 PrS Proposed sale
1.6
LAUREN MERENDINO

Officer

Officer
5,814
11.60
US$67,448 		5,814 11.60 US$67,448
2026-02-17 2026-02-17 PrS Proposed sale
3.0
ADAM DUBOW

Officer

Officer
6,395
11.60
US$74,188 		6,395 11.60 US$74,188
2025-11-18 2025-11-17 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
3,726 -6.8%
8.91
US$33,216 		3,726 -6.8% 8.91 US$33,216
2025-11-18 2025-11-17 S Sale
3.2
York Charles N II

COO and CFO

Officer
4,062 -1.4%
8.91
US$36,212 		4,062 -1.4% 8.91 US$36,212
2025-11-18 2025-11-17 S Sale
3.0
Dubow Adam

Gen Counsel & Secretary

Officer
4,319 -6.5%
8.91
US$38,503 		4,319 -6.5% 8.91 US$38,503
2025-11-18 2025-11-17 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
15,894 -8.2%
8.91
US$141,690 		15,894 -8.2% 8.91 US$141,690
2025-11-17 2025-11-17 PrS Proposed sale
3.2
CHARLES YORK

Officer

Officer
4,062
8.91
US$36,211 		4,062 8.91 US$36,211
2025-11-17 2025-11-17 PrS Proposed sale
1.6
LAUREN MERENDINO

Officer

Officer
3,726
8.91
US$33,216 		3,726 8.91 US$33,216
2025-11-17 2025-11-17 PrS Proposed sale
3.0
ADAM DUBOW

Officer

Officer
4,319
8.91
US$38,502 		4,319 8.91 US$38,502
2025-11-17 2025-11-17 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
15,894
8.91
US$141,689 		15,894 8.91 US$141,689
2025-08-19 2025-08-18 S Sale
3.2
York Charles N II

COO and CFO

Officer
4,106 -1.5%
6.77
US$27,786 		4,106 -1.5% 6.77 US$27,786
2025-08-19 2025-08-18 S Sale
3.0
Dubow Adam

Gen Counsel & Secretary

Officer
4,365 -7.4%
6.77
US$29,538 		4,365 -7.4% 6.77 US$29,538
2025-08-19 2025-08-18 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
16,058 -9.1%
6.77
US$108,666 		16,058 -9.1% 6.77 US$108,666
2025-08-19 2025-08-18 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
3,766 -8.2%
6.77
US$25,485 		3,766 -8.2% 6.77 US$25,485
2025-08-18 2025-08-18 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
16,058
6.77
US$108,666 		16,058 6.77 US$108,666
2025-05-19 2025-05-16 S Sale
1.6
Merendino Lauren

Chief Commercial Officer

Officer
3,927 -10.0%
6.26
US$24,575 		3,927 -10.0% 6.26 US$24,575
2025-05-19 2025-05-16 S Sale
3.0
Dubow Adam

GENERAL COUNSEL

Officer
4,552 -8.8%
6.26
US$28,486 		4,552 -8.8% 6.26 US$28,486
2025-05-19 2025-05-16 S Sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
4,282 -1.6%
6.26
US$26,796 		4,282 -1.6% 6.26 US$26,796
2025-05-19 2025-05-16 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
13,964 -8.7%
6.26
US$87,385 		13,964 -8.7% 6.26 US$87,385
2025-05-16 2025-05-16 PrS Proposed sale
3.2
CHARLES YORK

Officer

Officer
4,282
6.26
US$26,796 		4,282 6.26 US$26,796
2025-05-16 2025-05-16 PrS Proposed sale
1.6
LAUREN MERENDINO

Officer

Officer
3,927
6.26
US$24,575 		3,927 6.26 US$24,575
2025-05-16 2025-05-16 PrS Proposed sale
3.0
ADAM DUBOW

Officer

Officer
4,552
6.26
US$28,486 		4,552 6.26 US$28,486
2025-05-16 2025-05-16 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
13,964
6.26
US$87,385 		13,964 6.26 US$87,385
2025-02-21 2025-02-18 S Sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
4,370 -1.7%
11.96
US$52,278 		4,370 -1.7% 11.96 US$52,278
2025-02-21 2025-02-18 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
12,048 -8.6%
11.96
US$144,130 		12,048 -8.6% 11.96 US$144,130
2025-02-21 2025-02-18 S Sale
3.0
Dubow Adam

GENERAL COUNSEL

Officer
4,646 -10.5%
11.96
US$55,580 		4,646 -10.5% 11.96 US$55,580
2025-02-18 2025-02-18 PrS Proposed sale
3.0
ADAM DUBOW

Officer

Officer
4,646
11.96
US$55,580 		4,646 11.96 US$55,580
2025-02-18 2025-02-18 PrS Proposed sale
3.2
CHARLES YORK

Officer

Officer
4,370
11.96
US$52,278 		4,370 11.96 US$52,278
2025-02-18 2025-02-18 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
12,048
11.96
US$144,129 		12,048 11.96 US$144,129
2024-12-12 2024-12-10 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
30,000 -2.8%
13.31
US$399,339 		30,000 -2.8% 13.31 US$399,339
2024-11-19 2024-11-18 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
10,554 -8.9%
13.21
US$139,420 		10,554 -8.9% 13.21 US$139,420
2024-11-19 2024-11-18 S Sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
2,206 -0.2%
13.21
US$29,142 		2,206 -0.2% 13.21 US$29,142
2024-11-19 2024-11-18 S Sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
2,602 -1.1%
13.21
US$34,373 		2,602 -1.1% 13.21 US$34,373
2024-11-19 2024-11-18 S Sale
3.0
Dubow Adam

GENERAL COUNSEL

Officer
3,165 -9.0%
13.21
US$41,810 		3,165 -9.0% 13.21 US$41,810
2024-11-18 2024-11-18 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
2,206
13.21
US$29,142 		2,206 13.21 US$29,142
2024-11-18 2024-11-18 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
10,554
13.21
US$139,420 		10,554 13.21 US$139,420
2024-11-12 2024-11-11 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
50,000
16.39
US$819,500 		50,000 16.39 US$819,500
2024-11-12 2024-11-11 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
10,000 -0.9%
16.10
US$160,994 		10,000 -0.9% 16.10 US$160,994
2024-11-12 2024-11-08 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
18,255 -1.7%
16.17
US$295,229 		18,255 -1.7% 16.17 US$295,229
2024-11-08 2024-11-07 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
11,245 -1.0%
16.03
US$180,287 		11,245 -1.0% 16.03 US$180,287
2024-11-04 2024-10-31 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
500 -0.0%
16.02
US$8,010 		500 -0.0% 16.02 US$8,010
2024-10-31 2024-10-31 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
30,000
14.47
US$434,100 		30,000 14.47 US$434,100
2024-09-12 2024-09-10 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
30,000 -2.7%
14.22
US$426,675 		30,000 -2.7% 14.22 US$426,675
2024-08-19 2024-08-16 S Sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
2,633 -1.1%
14.00
US$36,860 		2,633 -1.1% 14.00 US$36,860
2024-08-19 2024-08-16 S Sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
2,232 -0.2%
14.00
US$31,246 		2,232 -0.2% 14.00 US$31,246
2024-08-19 2024-08-16 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
10,681 -9.7%
14.00
US$149,524 		10,681 -9.7% 14.00 US$149,524
2024-08-19 2024-08-16 S Sale
3.0
Dubow Adam

GENERAL COUNSEL

Officer
3,202 -10.6%
14.00
US$44,825 		3,202 -10.6% 14.00 US$44,825
2024-08-16 2024-08-16 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
10,681
14.00
US$149,524 		10,681 14.00 US$149,524
2024-08-16 2024-08-16 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
2,232
14.00
US$31,246 		2,232 14.00 US$31,246
2024-07-17 2024-07-16 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
20,000 -1.8%
16.01
US$320,226 		20,000 -1.8% 16.01 US$320,226
2024-07-16 2024-07-16 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
80,000
15.70
US$1,256,000 		80,000 15.70 US$1,256,000
2024-06-21 2024-06-21 PrS Proposed sale
1.8
SAIRA RAMASASTRY

Director

Non-Executive Director
10,000
13.19
US$131,877 		10,000 13.19 US$131,877
2024-06-21 2024-06-21 S Sale
1.8
Ramasastry Saira
Non-Executive Director
10,000 -19.8%
13.19
US$131,877 		10,000 -19.8% 13.19 US$131,877
2024-06-12 2024-06-10 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
30,000 -2.6%
12.62
US$378,588 		30,000 -2.6% 12.62 US$378,588
2024-06-10 2024-06-10 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
30,000
12.77
US$383,100 		30,000 12.77 US$383,100
2024-05-17 2024-05-16 S Sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
2,267 -0.2%
16.08
US$36,450 		2,267 -0.2% 16.08 US$36,450
2024-05-17 2024-05-16 S Sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
2,675 -1.2%
16.08
US$43,011 		2,675 -1.2% 16.08 US$43,011
2024-05-17 2024-05-16 S Sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
7,873 -1.2%
16.08
US$126,588 		7,873 -1.2% 16.08 US$126,588
2024-05-17 2024-05-16 S Sale
3.0
Dubow Adam

GENERAL COUNSEL

Officer
3,253 -13.0%
16.08
US$52,304 		3,253 -13.0% 16.08 US$52,304
2024-05-16 2024-05-16 PrS Proposed sale
3.0
ADAM DUBOW

Officer

Officer
3,253
16.08
US$52,304 		3,253 16.08 US$52,304
2024-05-16 2024-05-16 PrS Proposed sale
3.2
JEREMY BENDER

Officer; Director

Executive Director
7,873
16.08
US$126,587 		7,873 16.08 US$126,587
2024-05-16 2024-05-16 PrS Proposed sale
3.2
CHARLES YORK

Officer

Officer
2,675
16.08
US$43,010 		2,675 16.08 US$43,010
2024-05-16 2024-05-16 PrS Proposed sale
3.8
SAMUEL BLACKMAN

Officer

Officer
2,267
16.08
US$36,450 		2,267 16.08 US$36,450
2024-05-14 2024-05-10 PlS Planned sale
3.8
Blackman Samuel C.

HEAD OF R&D

Officer
10,000 -0.9%
16.37
US$163,743 		10,000 -0.9% 16.37 US$163,743
2024-05-03 2024-05-03 PlS Planned sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
9,154 -1.4%
17.85
US$163,417 		9,154 -1.4% 17.85 US$163,417
2024-05-03 2024-05-03 PlS Planned sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
8,078 -3.6%
17.85
US$144,214 		8,078 -3.6% 17.85 US$144,214
2024-05-03 2024-05-02 PlS Planned sale
3.2
Bender Jeremy

CHIEF EXECUTIVE OFFICER

Executive Director
6 -0.0%
17.94
US$108 		6 -0.0% 17.94 US$108
2024-05-03 2024-05-02 PlS Planned sale
3.2
York Charles N II

COO, CFO AND SECRETARY

Officer
200 -0.1%
17.90
US$3,579 		200 -0.1% 17.90 US$3,579
Explore more

More insider trading research around Day One Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America